413,414 These findings suggest that minihepcidins have the potential to be a future treatment for -thalassemia
Psychiatry 28 , 10041019 (2023)
This triple-action mechanism distinguishes it from existing approved agents such as semaglutide (a GLP-1 receptor agonist, approved in the UK as Wegovy and Ozempic) and tirzepatide (a dual GIP/GLP-1 receptor agonist, approved as Mounjaro), and is being studied primarily for obesity and type 2 diabetes management
For maintenance doses (1.0 to 2.4 mg) Higher concentrations (2.5 to 5 mg/mL) work better for maintenance doses because the draw volumes stay within syringe capacity
6-week washout: Recommended after a standard 12-week cycle
8 Include oily fish (salmon, mackerel, sardines) at least twice a week, along with walnuts, flaxseeds, and chia seeds